See ADAMS in Action

Unlocking Data. Unlocking Discovery.

Reinventing Life Sciences Innovation

The MDClone ADAMS Platform is a powerful, self-service data analytics environment that provides secure and dynamic collaboration capabilities between health systems and pharmaceutical organizations.

Implemented in medical centers worldwide, MDClone accelerates clinical trials by reducing time for site selection, accelerating patient recruitment, and reducing costs.

Your Details

Your Name(Required)

Your Questions and Barriers:

Today’s Barriers

Pharma Companies Face Complex, Long, and Costly Development Processes

Fragmented data assets, limited access to clinical information, and long timelines are limiting factors for life science organizations striving to innovate. 

At MDClone, we understand that gaps and limitations in life science data impact discoveries, outcomes, and revenue.

The Solution

Accelerate the Research and Discovery Process with Informed Decision-Making

MDClone connects life science organizations to rich patient data needed to test hypotheses, build models, validate studies, develop clinical trials, improve care optimization, and create life-saving therapies. Through a secure and controlled platform with embedded synthetic data technology, life science organizations can identify sites, analyze robust structured and unstructured real-world data, and explore populations of interest with incredible detail and flexibility.

Demonstrate Value Throughout the Research Lifecycle

Access unparalleled data for superior real-world evidence, health economics, and outcomes research. MDClone offers an all-in-one solution to accelerate discovery for clinical trial development, clinical trial site selection, care utilization and pathways, and clinical decision support.

Unmatched Data Granularity

Organized longitudinally and directly connected to source systems, the platform spans 20+ global sites, 30+ years, and includes 50M+ unique patient records across the U.S., Canada, and Israel.

Your Details

Your Name(Required)

Your Questions and Barriers:

Discover the Features of the MDClone ADAMS Platform

Invite-in Subscription Model

Unlike traditional data-sharing agreements, MDClone enables a subscription model to enable collaboration between health systems and third parties, such as life science organizations, data scientists, researchers, and administrators. Leveraging MDClone’s unique technology, interested parties are “invited in” and provided access to a virtual environment for dynamic data exploration.

Dynamic Exploration of Robust Data

Rapid and robust insight discovery is enabled by MDClone’s ADAMS Platform. Third parties can define cohorts of interest, including detailed inclusion and exclusion criteria (demographics, diagnoses, medications, etc.) and any time-related events (outcomes, labs, diagnoses, medications, procedures, admissions, etc.). ADAMS is designed for use without advanced programming skills or any knowledge of a specific health system database.

Patient Privacy Protection with Synthetic Data

MDClone is the healthcare industry’s leading provider of synthetic data, a powerful technology that moves beyond de-identification techniques to provide unprecedented privacy and utility. Synthetic data produced in MDClone is computationally derived, created based on real patient data, and designed to closely mimic the data without sharing any individual patient information.

Key Benefits

Explore Structured and Unstructured Data Elements

Leverage Diverse Data Feeds Directly at the Health System Source

Collaborate with Leading Global Health Systems

Test Hypotheses, Validate Models, and Deploy Solutions in Rapid Cycles

Ready to Ask Your Own Research Questions?

Discover the powerful capabilities of The ADAMS healthcare data platform in action.

Send us your pressing research question and our team of clinician research experts will send you a FREE custom video demonstrating how our innovative platform can unlock your data.

Your Details

Your Name(Required)

Your Questions and Barriers: